Literature DB >> 14470044

Functioning islet cell tumors of the pancreas. 25-year follow up.

A M MARKOWITZ, C A SLANETZ, V K FRANTZ.   

Abstract

Entities:  

Keywords:  ISLET CELL TUMOR; PANCREAS/neoplasms

Mesh:

Year:  1961        PMID: 14470044      PMCID: PMC1465921     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  Ulcerogenic tumors of the pancreas.

Authors:  R M ZOLLINGER; R C McPHERSON
Journal:  Am J Surg       Date:  1958-03       Impact factor: 2.565

2.  Tumors associated with hypoglycemia; pancreatic and extrapancreatic.

Authors:  V K FRANTZ; M R PORTER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

3.  The ulcerogenic tumor of the pancreas.

Authors:  E H ELLISON
Journal:  Surgery       Date:  1956-07       Impact factor: 3.982

4.  Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.

Authors:  R M ZOLLINGER; E H ELLISON
Journal:  Ann Surg       Date:  1955-10       Impact factor: 12.969

5.  Hypoglycemia in relation to duodenal ulcer.

Authors:  L C BECK
Journal:  J Am Geriatr Soc       Date:  1954-07       Impact factor: 5.562

6.  Adenomatosis of Islet Cells, With Hyperinsulinism.

Authors:  V K Frantz
Journal:  Ann Surg       Date:  1944-06       Impact factor: 12.969

7.  TUMORS OF ISLET CELLS WITH HYPERINSULINISM; BENIGN, MALIGNANT, AND QUESTIONABLE.

Authors:  V K Frantz
Journal:  Ann Surg       Date:  1940-08       Impact factor: 12.969

8.  ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW.

Authors:  A O Whipple; V K Frantz
Journal:  Ann Surg       Date:  1935-06       Impact factor: 12.969

9.  Islet-celled tumour of the pancreas with unusual clinico-pathological features.

Authors:  L CUNNINGHAM; P HAWE; R W EVANS
Journal:  Br J Surg       Date:  1952-01       Impact factor: 6.939

10.  Functioning pancreatic islet cell adenomas; a review of the literature and presentation of two new differential tests.

Authors:  E L CRAIN; G W THORN
Journal:  Medicine (Baltimore)       Date:  1949-12       Impact factor: 1.889

View more
  10 in total

1.  THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

Authors:  E H ELLISON; S D WILSON
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  Ectopic apudocarcinomas and associated endocrine hyperplasias of the foregut.

Authors:  S R Friesen; J E McGuigan
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

3.  Multiple adenomatosis presenting with psychiatric manifestations.

Authors:  M W Carney; I Weinbren; F Jackson; G V Purnell
Journal:  Postgrad Med J       Date:  1971-04       Impact factor: 2.401

4.  Insulinoma in childhood.

Authors:  J R Mann; P H Rayner; A Gourevitch
Journal:  Arch Dis Child       Date:  1969-08       Impact factor: 3.791

Review 5.  Hormone-secreting tumours of the pancreas.

Authors:  R B Welbourn; A P Barabas
Journal:  Postgrad Med J       Date:  1967-01       Impact factor: 2.401

6.  The surgical aspects of insulinomas.

Authors:  J A van Heerden; A J Edis; F J Service
Journal:  Ann Surg       Date:  1979-06       Impact factor: 12.969

7.  Diabetes after removal of insulin tumours of pancreas: a long-term follow-up survey of 11 patients.

Authors:  D C Dunn
Journal:  Br Med J       Date:  1971-04-10

8.  Zollinger-Ellison syndrome: special considerations.

Authors:  J D Hardy; P D Doolittle
Journal:  Ann Surg       Date:  1977-06       Impact factor: 12.969

9.  Insulinoma and anaesthetic implications.

Authors:  Jyotsna Goswami; Pallavi Somkuwar; Yogesh Naik
Journal:  Indian J Anaesth       Date:  2012-03

10.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.